Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis?

Journal of Hepatology

Volumn 33, Issue 6, 2000, Pages 873-877

  Bergquist, Annika ^a,b   Tribukait, Bernhard ^b   Glaumann, Hans ^a   Broomé, Ulrika ^a  

^a Department of Gastroenterology and HepatologySweden ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholangiocarcinoma; Cytometry; DNA ploidy; Primary sclerosing cholangitis

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHOLANGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; PLOIDY; PRECANCER; PRIORITY JOURNAL;

EID: 0033645976     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80117-8     Document Type: Article

References (35)

1. Significance of aneuploidy
2. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma
3. Nuclear DNA content and pathology in radically treated pancreatic carcinoma
4. Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukes' classification and histopathological differentiation
5. DNA Aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
6. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis
7. Early detection of malignancy in ulcerative colitis. A flowcytometric DNA study
8. Endoscopic biopsy can detect high grade dysplasia or early adenocarcinoma in Barret's esophagus without grossly recognizable neoplastic lesions
9. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer
10. Apoptosis and bile duct cell dysplasia in patients with primary sclerosing cholangitis with and without cholangiocarcinoma
11. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma
12. The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis
13. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
14. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis
15. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
16. Cholangiocarcinoma complicating primary sclerosing cholangitis
17. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis - A case control study
18. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis
19. Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
20. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation
21. Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation
22. 'Natural history' of unresected cholangiocarcinoma: Patient outcome after noncurative resection
23. Clinicopathologic features of the syndrome of primary sclerosing cholangitis
24. Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology
25. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area
26. Histological typing of gallbladder and extrahepatic bile ducts
27. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase
28. DNA image analysis study of the gallbladder and biliary system
29. Liver transplantation for primary sclerosing cholangitis: Impact of riskfactors and outcome
30. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study in 65 patients with bile duct strictures
31. A prospective evaluation of cytology from biliary strictures
32. Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography
33. Nuclear DNA content, proliferating index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors
34. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis